Phase II, single center, non-controlled, open-label study of liposomal prostaglandin E1 (Liprostin) as adjunct therapy with lower limb angioplasty in patients with ischemic and non-ischemic peripheral arterial occlusive disease
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Alprostadil (Primary)
- Indications Peripheral arterial occlusive disorders
- Focus Therapeutic Use
- 30 Oct 2005 New trial record.